Michael Lawsky Email

President Corporate Functions, Chief Corporate Development & Strategy Officer . L-Nutra

Current Roles

Employees:
69
Revenue:
$16.8M
About
L-Nutra is the leading nutritechnology company, developing innovative Fasting Mimicking Diets (FMD) that can be consumed for a predetermined number of consecutive days, with the frequency dependent on the condition and patient. FMDs nourish the body while keeping it in a fasting mode, which promotes positive long-term effects on biological aging, health and a variety of other factors, such as weight, abdominal fat , and maintaining healthy levels of glucose, cholesterol, blood pressure, and other key health factors. L-Nutra's first generation of FMDs includes ProLon® and Chemolieve®. ProLon is a 5-day FMD aimed at promoting longevity, managing body weight, and improving health by supporting cellular protection, multi-system regeneration and rejuvenation. ProLon launched in the United States in 2016. Chemolieve is a 4-day FMD being studied for use with oncology patients to protect the normal cells of the body and decrease side effects of chemotherapy without interfering with its efficacy.
L-Nutra Address
2034 Armacost Ave
Los Angeles, CA
United States

Past Companies

L-Nutra, IncPresident Corporate | Chief Corporate Development & Strategy Officer
L-Nutra, IncChief Corporate Development Officer
FinseraAdvisor

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.